Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adrenomedullin and Outcome in Severe Sepsis and Septic Shock. The AdrenOSS Study.

NCT02393781 is registered in ClinicalTrials.gov with Sphingotec GmbH as lead sponsor.

NCT NCT02393781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02393781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adrenomedullin and Outcome in Severe Sepsis and Septic Shock. The AdrenOSS Study.
Lead sponsor
Sphingotec GmbH
Phase
Observational
Overall status
Completed
Start date
June 30, 2015
Completion date
June 30, 2016
Enrollment
596 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock, severe sepsis